Published in Cytotechnology on September 01, 1998
Resistance to cancer chemotherapy: failure in drug response from ADME to P-gp. Cancer Cell Int (2015) 0.84
Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma. N Engl J Med (1991) 19.46
Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature (1992) 18.26
Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res (1989) 12.85
The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim Biophys Acta (1991) 11.78
Activation of transcription by two factors that bind promoter and enhancer sequences of the human metallothionein gene and SV40. Nature (1987) 6.76
Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest (1989) 5.71
Gene amplification in cultured animal cells. Cell (1984) 5.43
The relation between cell proliferation and the vascular system in a transplanted mouse mammary tumour. Br J Cancer (1968) 4.88
Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors. Breast Cancer Res Treat (1995) 3.88
Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck. Radiother Oncol (1996) 3.59
The relevance of tumour pH to the treatment of malignant disease. Radiother Oncol (1984) 3.44
Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapy. Int J Radiat Oncol Biol Phys (1988) 2.95
Mechanism of multidrug resistance. Biochim Biophys Acta (1988) 2.83
Hypoxia and drug resistance. Cancer Metastasis Rev (1994) 2.18
Oxygen in human tumors: correlations between methods of measurement and response to therapy. Summary of a workshop held November 19-20, 1992, at the National Cancer Institute, Bethesda, Maryland. Radiat Res (1993) 1.99
Classification of antineoplastic agents by their selective toxicities toward oxygenated and hypoxic tumor cells. Cancer Res (1981) 1.91
Association of vascular endothelial growth factor expression with intratumoral microvessel density and tumour cell proliferation in human epidermoid lung carcinoma. Br J Cancer (1996) 1.84
Tumor oxygenation: a new predictive parameter in locally advanced cancer of the uterine cervix. Gynecol Oncol (1993) 1.79
Review article: angiogenesis, neovascular proliferation and vascular pathophysiology as targets for cancer therapy. Br J Radiol (1993) 1.77
Inhibition of angiogenesis. Semin Cancer Biol (1992) 1.72
Proliferation-dependent cytotoxicity of anticancer agents: a review. Cancer Res (1975) 1.63
Transient hypoxia enhances the frequency of dihydrofolate reductase gene amplification in Chinese hamster ovary cells. Proc Natl Acad Sci U S A (1986) 1.61
Tumor angiogenesis predicts clinical outcome of node-positive breast cancer patients treated with adjuvant hormone therapy or chemotherapy. Cancer J Sci Am (2006) 1.54
Hypoxia-mediated induction of acidic/basic fibroblast growth factor and platelet-derived growth factor in mononuclear phagocytes stimulates growth of hypoxic endothelial cells. Proc Natl Acad Sci U S A (1995) 1.52
Tumor hypoxia: its impact on cancer therapy. Cancer Metastasis Rev (1987) 1.48
Tumor angiogenesis: review of current applications in tumor prognostication. Semin Diagn Pathol (1993) 1.46
Activation of AP-1 and of a nuclear redox factor, Ref-1, in the response of HT29 colon cancer cells to hypoxia. Mol Cell Biol (1994) 1.39
Hypoxia and Radiation Response in Human Tumors. Semin Radiat Oncol (1996) 1.33
Tumor tissue oxygenation as evaluated by computerized-pO2-histography. Int J Radiat Oncol Biol Phys (1990) 1.26
Overexpression of P-glycoprotein and glutathione S-transferase-pi in resistant non-small cell lung carcinomas of smokers. Br J Cancer (1991) 1.25
Intercapillary distance, oxygen tension and local recurrence in cervix cancer. Scand J Clin Lab Invest Suppl (1968) 1.24
Measuring Tumor Hypoxia. Semin Radiat Oncol (1996) 1.22
Structure of the human genomic glutathione S-transferase-pi gene. Gene (1989) 1.13
Intercapillary distance measurement as an indicator of hypoxia in carcinoma of the cervix uteri. Int J Radiat Oncol Biol Phys (1986) 1.12
Drug resistance in Chinese hamster ovary cells during recovery from severe hypoxia. J Natl Cancer Inst (1989) 1.11
Effect of transient hypoxia on sensitivity to doxorubicin in human and murine cell lines. J Natl Cancer Inst (1990) 1.04
Tumor Hypoxia and Heterogeneity: Challenges and Opportunities for the Future. Semin Radiat Oncol (1996) 1.03
Frequencies of independent and simultaneous selection of Chinese hamster cells for methotrexate and doxorubicin (adriamycin) resistance. Proc Natl Acad Sci U S A (1987) 1.02
Oxygenation of human tumors. Strahlenther Onkol (1990) 1.02
Hypoxia-induced drug resistance: comparison to P-glycoprotein-associated drug resistance. Br J Cancer (1991) 1.00
Variation of vascular density within and between tumors of the uterine cervix and its predictive value for radiotherapy. Int J Radiat Oncol Biol Phys (1989) 0.98
Regulation of c-jun expression during hypoxic and low-glucose stress. Mol Cell Biol (1994) 0.96
Physiologic mechanisms of therapeutic resistance. Blood flow and hypoxia. Hematol Oncol Clin North Am (1995) 0.95
Effects of hypoxia on detoxicating enzyme activity and expression in HT29 colon adenocarcinoma cells. Cancer Res (1994) 0.94
Use of hypoxia-directed drugs in the therapy of solid tumors. Semin Oncol (1992) 0.94
Enhanced synthesis of specific proteins, RNA, and DNA caused by hypoxia and reoxygenation. Int J Radiat Oncol Biol Phys (1989) 0.94
Interrelationships between microvessel density, expression of VEGF and resistance to doxorubicin of non-small lung cell carcinoma. Anticancer Res (1996) 0.92
Anticancer strategies involving the vasculature: vascular targeting and the inhibition of angiogenesis. Semin Cancer Biol (1992) 0.92
Cross-resistance and glutathione-S-transferase-pi levels among four human melanoma cell lines selected for alkylating agent resistance. Cancer Res (1989) 0.88
Vascular density in carcinoma of the uterine cervix and its predictive value for radiotherapy. Int J Cancer (1988) 0.87
Vascularization and curability of stage III and IV nasopharyngeal tumors. J Cancer Res Clin Oncol (1988) 0.85
Association of resistance-related protein expression with poor vascularization and low levels of oxygen in human rectal cancer. Int J Cancer (1996) 0.84
The effect of hypoxia on acquired drug resistance and response to epidermal growth factor in Chinese hamster lung fibroblasts and human breast-cancer cells in vitro. Int J Cancer (1993) 0.84
Metallothionein IIA is up-regulated by hypoxia in human A431 squamous carcinoma cells. Cancer Res (1994) 0.82
Up-regulation of resistance-related proteins in human lung tumors with poor vascularization. Carcinogenesis (1995) 0.81
Microvessel density and vascular endothelial growth factor expression in human tumors of different localization. Oncol Rep (1996) 0.79
Oxygen tension and vascular density in human cervix carcinoma. Br J Cancer (1996) 0.78
Nitroaryl compounds as potential fluorescent probes for hypoxia. I. Chemical criteria and constraints. Int J Radiat Oncol Biol Phys (1984) 0.78
Overexpression of C-fos and C-erbb1 encoded proteins in squamous-cell carcinomas of the lung of smokers. Int J Oncol (1992) 0.76
P-glycoprotein associated expression of c-fos and c-jun products in human lung carcinomas. Anticancer Res (1993) 0.76
Sulforaphane targets pancreatic tumour-initiating cells by NF-kappaB-induced antiapoptotic signalling. Gut (2008) 2.36
Severe hyperphosphatemia and hypocalcemia caused by bowel preparation for colonoscopy using oral sodium phosphate in end-stage renal disease. Endoscopy (2005) 2.23
Association of vascular endothelial growth factor expression with intratumoral microvessel density and tumour cell proliferation in human epidermoid lung carcinoma. Br J Cancer (1996) 1.84
VEGF expression by mesenchymal stem cells contributes to angiogenesis in pancreatic carcinoma. Br J Cancer (2008) 1.84
Pathophysiologic basis of contrast enhancement in breast tumors. J Magn Reson Imaging (1999) 1.81
Prognostic value of vascular endothelial growth factor and its receptor Flt-1 in squamous cell lung cancer. Int J Cancer (1997) 1.51
Pretherapeutic detection of tumour resistance and the results of tumour chemotherapy. Eur J Cancer (1979) 1.49
Immunohistochemical detection of the multi-drug-resistance marker P-glycoprotein in uterine cervical carcinomas and normal cervical tissue. Am J Obstet Gynecol (1992) 1.43
P-glycoprotein expression in treated and untreated human breast cancer. Br J Cancer (1989) 1.39
Overexpression of P-glycoprotein and glutathione S-transferase-pi in resistant non-small cell lung carcinomas of smokers. Br J Cancer (1991) 1.25
Effect of highly active antiretroviral therapy on survival in patients with AIDS-associated pulmonary Kaposi's sarcoma treated with chemotherapy. J Clin Oncol (2001) 1.18
Tissue-factor expression in human non-small-cell lung carcinoma measured by immunohistochemistry: correlation between tissue factor and angiogenesis. Int J Cancer (1998) 1.18
The novel c-Met inhibitor cabozantinib overcomes gemcitabine resistance and stem cell signaling in pancreatic cancer. Cell Death Dis (2013) 1.17
Clinical relevance of predictive tests for cancer chemotherapy. Cancer Treat Rev (1982) 1.16
Prognostic relevance of ploidy, proliferation, and resistance-predictive tests in ovarian carcinoma. Cancer Res (1985) 1.15
Expression of Fas (CD95/APO-1) and Fas ligand in lung cancer, its prognostic and predictive relevance. Int J Cancer (1999) 1.10
Depressive action of serum of partially hepatectomized rats on tumour cells in vitro. Eur J Cancer (1967) 1.08
Tumour induction in the rodent Mastomys natalensis by activation of endogenous papilloma virus genomes. Nature (1984) 1.05
DNA distribution in non-small-cell lung carcinomas and its relationship to clinical behavior. Cytometry (1985) 1.04
Glucose-related protein (GRP78) and its relationship to the drug-resistance proteins P170, GST-pi, LRP56 and angiogenesis in non-small cell lung carcinomas. Anticancer Res (2000) 1.02
Prognostic significance of DNA patterns and resistance-predictive tests in non-small cell lung carcinoma. Cancer (1985) 1.00
Immunocytochemical detection of a resistance-associated glycoprotein in tissue culture cells, ascites tumors and human tumor xenografts by Mab 265/F4. Anticancer Res (1988) 1.00
Cytotoxic T lymphocytes with a grafted recognition specificity for ERBB2-expressing tumor cells. Proc Natl Acad Sci U S A (1994) 0.99
Reciprocal correlation between expression of P-glycoprotein and accumulation of rhodamine 123 in human tumors. Anticancer Res (1990) 0.98
[Selective tumour chemotherapy using oncobiograms (author's transl)]. Dtsch Med Wochenschr (1974) 0.97
Corticosteroid-induced chemotherapy resistance in urological cancers. Cancer Biol Ther (2006) 0.97
Five-year follow-up study of independent clinical and flow cytometric prognostic factors for the survival of patients with non-small cell lung carcinoma. Cancer Res (1988) 0.96
Detection of the multidrug resistant phenotype in human tumours by monoclonal antibodies and the streptavidin-biotinylated phycoerythrin complex method. Eur J Cancer Clin Oncol (1989) 0.96
Cyclin A is associated with an unfavourable outcome in patients with non-small-cell lung carcinomas. Br J Cancer (1997) 0.96
Improved lentiviral transduction of human mesenchymal stem cells for therapeutic intervention in pancreatic cancer. Cancer Gene Ther (2008) 0.95
Coexpression of VEGF and bFGF in human epidermoid lung carcinoma is associated with increased vessel density. Anticancer Res (1997) 0.95
Prognostic value of basic fibroblast growth factor and its receptor (FGFR-1) in patients with non-small cell lung carcinomas. Eur J Cancer (1997) 0.94
Growth of human bronchial carcinomas in nude mice. Br J Cancer (1985) 0.93
Human tumor xenografts as model for drug testing. Cancer Metastasis Rev (1988) 0.93
[Possibilities and limits of pre-therapeutic neoplasm sensitivity cytostatics tests under short-term conditions]. Schweiz Med Wochenschr (1975) 0.93
Vascular endothelial growth factor in newly diagnosed and recurrent childhood acute lymphoblastic leukemia as measured by real-time quantitative polymerase chain reaction. Clin Cancer Res (2001) 0.92
Interrelationships between microvessel density, expression of VEGF and resistance to doxorubicin of non-small lung cell carcinoma. Anticancer Res (1996) 0.92
[Quick method for sensitivity tests of malignant tumors against antineoplastic agents]. Klin Wochenschr (1970) 0.90
Overexpression of oncoproteins in non-small cell lung carcinomas of smokers. Carcinogenesis (1993) 0.90
Dexamethasone desensitizes hepatocellular and colorectal tumours toward cytotoxic therapy. Cancer Lett (2005) 0.90
Detection of drug resistance and P-glycoprotein in human renal cell carcinomas. Eur Urol (1990) 0.90
Analysis of c-fos, c-jun, c-erbB1, c-erbB2 and c-myc in primary lung carcinomas and their lymph node metastases. Clin Exp Metastasis (1994) 0.89
Incorporation of 131 iododeoxyuridine into the DNA of tumour-bearing rats after partial synchronization as a tool in scintigraphic tumour localization. Nucl Med (Stuttg) (1974) 0.89
Vascular endothelial growth-factor expression and angiogenesis in nonsmall cell lung carcinomas. Int J Oncol (1995) 0.89
Angiogenic growth factors and their receptors in non-small cell lung carcinomas and their relationships to drug response in vitro. Anticancer Res (1997) 0.88
Resistance mechanisms and their regulation in lung cancer. Crit Rev Oncog (1996) 0.88
Oncoprotein (c-myc, c-erbB1, c-erbB2, c-fos) and suppressor gene product (p53) expression in squamous cell carcinomas of the lung. Clinical and biological correlations. Anticancer Res (1992) 0.88
Induction of apoptosis in experimental human B cell lymphomas by conditional TRAIL-expressing T cells. Br J Cancer (2003) 0.88
Clinical correlates of in vitro effect of adriamycin on advanced lung carcinoma. Klin Wochenschr (1976) 0.88
Smoking-related increase of O6-methylguanine-DNA methyltransferase expression in human lung carcinomas. Carcinogenesis (1998) 0.87
Induced multidrug-resistance in murine sarcoma 180 cells grown in vitro and in vivo and associated changes in expression of multidrug-resistance DNA-sequences and membrane glycoproteins. Anticancer Res (1989) 0.87
Relationship between the expression of caspase-3 and the clinical outcome of patients with non-small cell lung cancer. Anticancer Res (2000) 0.87
Cephalic-phase insulin in obese and normal-weight men: relation to postprandial insulin. Metabolism (1993) 0.86
Relationship of inherent resistance to doxorubicin, proliferative activity and expression of P-glycoprotein 170, and glutathione S-transferase-pi in human lung tumors. Cancer (1992) 0.86
Apoptosis mediated by lentiviral TRAIL transfer involves transduction-dependent and -independent effects. Cancer Gene Ther (2006) 0.86
Use of tritiated nucleotide incorporation for prediction of sensitivity of tumors to cytostatic agents. Behring Inst Mitt (1984) 0.86
Prediction of the clinical chemotherapeutic response of stage III lung adenocarcinoma patients by an in vitro short term test. Br J Cancer (1988) 0.86
Inverse correlation between apoptotic (Fas ligand, caspase-3) and angiogenic factors (VEGF, microvessel density) in squamous cell lung carcinomas. Anticancer Res (1999) 0.86
The use of hyperventilation therapy after traumatic brain injury in Europe: an analysis of the BrainIT database. Intensive Care Med (2008) 0.86
PD-ECGF, bFGF, and VEGF expression in non-small cell lung carcinomas and their association with lymph node metastasis. Anticancer Res (1999) 0.86
Specific resistance upon lentiviral TRAIL transfer by intracellular retention of TRAIL receptors. Cell Death Differ (2006) 0.86
Association of vascular endothelial growth factor expression with tumor cell proliferation in ovarian carcinoma. Anticancer Res (1997) 0.85
Concurrent paclitaxel and radiation therapy for breast cancer. Semin Radiat Oncol (1999) 0.85
Messenger RNA expression of resistance proteins and related factors in human ovarian carcinoma cell lines resistant to doxorubicin, taxol and cisplatin. Anticancer Drugs (1997) 0.85
Protein expression profiles indicative for drug resistance of non-small cell lung cancer. Br J Cancer (2002) 0.85
Sensitivity tests of tumors to cytostatic agents. I. Comparative investigations on transplanted tumors in vivo and in vitro. Z Krebsforsch Klin Onkol Cancer Res Clin Oncol (1975) 0.84
Isopycnic density-gradient centrifugation: a separation parameter which improves flow cytometric measurements on heterogeneous tumors. Cytometry (1983) 0.84
[Incorporation of a 131-iodine-deoxycytidine monophosphate protamine complex into the DNA of tumor-bearing rats following partial synchronization with hydroxyurea]. Nucl Med (Stuttg) (1975) 0.84
Dexamethasone-induced cisplatin and gemcitabine resistance in lung carcinoma samples treated ex vivo. Br J Cancer (2005) 0.84
Association of resistance-related protein expression with poor vascularization and low levels of oxygen in human rectal cancer. Int J Cancer (1996) 0.84
O6-methylguanine-DNA methyltransferase activity and sensitivity to cyclophosphamide and cisplatin in human lung tumor xenografts. Int J Cancer (1998) 0.84
Kinetic complexity of nuclear poly(A)-containing RNA in normal and regenerating rat liver. Eur J Biochem (1979) 0.84
Occurrence of a multidrug-resistant phenotype in human lung xenografts. Br J Cancer (1987) 0.83
An alternative assay system for the detection of transforming genes. Carcinogenesis (1984) 0.83
Induced multidrug resistance in murine leukemia L1210 and associated changes in a surface-membrane glycoprotein. J Cancer Res Clin Oncol (1989) 0.83
[Individual chemotherapy of solid tumors]. Med Welt (1976) 0.82
Sensitivity tests of tumors to cytostatic agents. II. Investigation on human tumors. Z Krebsforsch Klin Onkol Cancer Res Clin Oncol (1975) 0.82
Intrinsic drug resistance in a human lung carcinoma xenograft is associated with overexpression of multidrug-resistance DNA-sequences and of plasma membrane glycoproteins. Arzneimittelforschung (1988) 0.82
Reversal of doxorubicin-resistance in sarcoma 180 tumor cells by inhibition of different resistance mechanisms. Cancer Lett (1993) 0.82
Correlation between successful heterotransplantation of lung tumors in nude mice, poor prognosis of patients and expression of Fos, Jun, ErbB1, and Ras. Anticancer Res (1994) 0.82
Resistance to doxorubicin in tumor cells in vitro and in vivo after pretreatment with verapamil. Chemotherapy (1991) 0.82
Analysis of cyclin D1 in de novo and relapsed childhood acute lymphoblastic leukemia. Anticancer Res (1999) 0.82
Up-regulation of heat shock protein 70 in adenocarcinomas of the lung in smokers. Anticancer Res (1996) 0.82